Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression

NCT02600494 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

554

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Depression

Interventions

DRUG: ITI-007 (Lumateperone)
DRUG: Placebo

Sponsor

Intra-Cellular Therapies, Inc.